Cargos activos de Jean-Paul Renaud
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Urania Therapeutics SAS
 Urania Therapeutics SAS BiotechnologyHealth Technology Urania Therapeutics SAS develops therapeutic solutions for the treatment of genetic diseases caused by pathogenic nonsense mutations. The company was founded by Jean-Paul Renaud, Marat Yusupova, and Gulnara Yusupova in October 2015 and is headquartered in Illkirc, France. | Director/Miembro de la Junta | 01/10/2015 | - |
| Director Técnico/Científico/I+D | 01/10/2015 | - | |
| Fundador | 01/10/2015 | - | |
| Presidente | 01/10/2015 | - |
Historial de carrera de Jean-Paul Renaud
Antiguos cargos conocidos de Jean-Paul Renaud.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
NovAliX SAS
 NovAliX SAS BiotechnologyHealth Technology NovAliX SAS operates as a drug discovery-focused contract research organization. It offers drug discovery services in the fields of chemistry, collaborative models, biophysics and biology. The company was founded by Stephan Jenn and Jean-Paul Renaud in 2002 and is headquartered in Illkirch, France. | Director Técnico/Científico/I+D | 01/01/2002 | - |
| Fundador | 01/01/2002 | - |
Estadísticas
Internacional
| Francia | 3 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
NovAliX SAS
NovAliX SAS BiotechnologyHealth Technology NovAliX SAS operates as a drug discovery-focused contract research organization. It offers drug discovery services in the fields of chemistry, collaborative models, biophysics and biology. The company was founded by Stephan Jenn and Jean-Paul Renaud in 2002 and is headquartered in Illkirch, France. | Health Technology |
Urania Therapeutics SAS
Urania Therapeutics SAS BiotechnologyHealth Technology Urania Therapeutics SAS develops therapeutic solutions for the treatment of genetic diseases caused by pathogenic nonsense mutations. The company was founded by Jean-Paul Renaud, Marat Yusupova, and Gulnara Yusupova in October 2015 and is headquartered in Illkirc, France. | Health Technology |
- Bolsa de valores
- Insiders
- Jean-Paul Renaud
- Experiencia
